Cargando…
Mutant p53(R211*) ameliorates inflammatory arthritis in AIA rats via inhibition of TBK1-IRF3 innate immune response
BACKGROUND: Rheumatoid arthritis (RA) is an autoimmune inflammation disease characterized by imbalance of immune homeostasis. p53 mutants are commonly described as the guardian of cancer cells by conferring them drug-resistance and immune evasion. Importantly, p53 mutations have also been identified...
Autores principales: | Zeng, Yaling, Ng, Jerome P. L., Wang, Linna, Xu, Xiongfei, Law, Betty Yuen Kwan, Chen, Guobing, Lo, Hang Hong, Yang, Lijun, Yang, Jiujie, Zhang, Lei, Qu, Liqun, Yun, Xiaoyun, Zhong, Jing, Chen, Ruihong, Zhang, Dingqi, Wang, Yuping, Luo, Weidan, Qiu, Congling, Huang, Baixiong, liu, Wenfeng, Liu, Liang, Wong, Vincent Kam Wai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10656327/ https://www.ncbi.nlm.nih.gov/pubmed/37935918 http://dx.doi.org/10.1007/s00011-023-01809-w |
Ejemplares similares
-
N-Acetylcysteine overcomes epalrestat-mediated increase of toxic 4-hydroxy-2-nonenal and potentiates the anti-arthritic effect of epalrestat in AIA model
por: Wang, Linna, et al.
Publicado: (2023) -
TANK-Binding Kinase 1 (TBK1) Isoforms Negatively Regulate Type I Interferon Induction by Inhibiting TBK1-IRF3 Interaction and IRF3 Phosphorylation
por: Hu, Yi Wei, et al.
Publicado: (2018) -
Identification of TBK1 complexes required for the phosphorylation of IRF3 and the production of interferon β
por: Bakshi, Siddharth, et al.
Publicado: (2017) -
The chemotherapeutic agent DMXAA potently and specifically activates the TBK1–IRF-3 signaling axis
por: Roberts, Zachary J., et al.
Publicado: (2007) -
PGAM5-MAVS interaction regulates TBK1/ IRF3 dependent antiviral responses
por: Yu, Yu-qiang, et al.
Publicado: (2020)